Literature DB >> 29984419

Reply to the letter from Barra et al.

Sachiko Matsuzaki1,2, Jean-Luc Pouly1,2, Michel Canis1,2.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 29984419      PMCID： PMC6086979          DOI： 10.1111/bph.14390

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN： 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  7 in total

1.  Everolimus as an mTOR Inhibitor Suppresses Endometriotic Implants: an Experimental Rat Study.

Authors:  T Kacan; C Yildiz; S Baloglu Kacan; M Seker; H Ozer; A Cetin
Journal:  Geburtshilfe Frauenheilkd       Date:  2017-01       Impact factor: 2.915

2.  Reply to the letter from Barra et al.

Authors:  Sachiko Matsuzaki; Jean-Luc Pouly; Michel Canis
Journal:  Br J Pharmacol       Date:  2018-07-08       Impact factor: 8.739

3.  Co-operation between the AKT and ERK signaling pathways may support growth of deep endometriosis in a fibrotic microenvironment in vitro.

Authors:  Sachiko Matsuzaki; Claude Darcha
Journal:  Hum Reprod       Date:  2015-05-14       Impact factor: 6.918

4.  In vitro and in vivo effects of MK2206 and chloroquine combination therapy on endometriosis: autophagy may be required for regrowth of endometriosis.

Authors:  Sachiko Matsuzaki; Jean-Luc Pouly; Michel Canis
Journal:  Br J Pharmacol       Date:  2018-04-16       Impact factor: 8.739

5.  The mTOR/AKT inhibitor temsirolimus prevents deep infiltrating endometriosis in mice.

Authors:  Mahaut Leconte; Carole Nicco; Charlotte Ngô; Christiane Chéreau; Sandrine Chouzenoux; Wioleta Marut; Jean Guibourdenche; Sylviane Arkwright; Bernard Weill; Charles Chapron; Bertrand Dousset; Frédéric Batteux
Journal:  Am J Pathol       Date:  2011-06-12       Impact factor: 4.307

Review 6.  Influence of AKT on progesterone action in endometrial diseases.

Authors:  Irene I Lee; J Julie Kim
Journal:  Biol Reprod       Date:  2014-08-06       Impact factor: 4.285

7.  Effects of U0126 and MK2206 on cell growth and re-growth of endometriotic stromal cells grown on substrates of varying stiffness.

Authors:  Sachiko Matsuzaki; Jean-Luc Pouly; Michel Canis
Journal:  Sci Rep       Date:  2017-02-20       Impact factor: 4.379
  7 in total
  1 in total

1.  Reply to the letter from Barra et al.

Authors:  Sachiko Matsuzaki; Jean-Luc Pouly; Michel Canis
Journal:  Br J Pharmacol       Date:  2018-07-08       Impact factor: 8.739
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.